Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world re-opens for business. However, others may turn out to be classic value traps. Read on for our usual insightful comment.
James Halstead: another dividend increase
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Anexo Group PLC
Focus on the cash flow
Results and updates from AIM companies covered here extend from the fast growers to…
Some welcome good news at last for shareholders in this provider of online competitions to win…
Yet another AIM company is set to be acquired by private equity, with management clearly of…
2022 has been torrid year for new issues on AIM so it’s great to see London's…
Updates from AIM covered here includes news of the suspension of trading in the shares of a…
Results and updates covered here include simplicity and excellence from an AIM elder and complexity and…
The shares of technology stocks are plummeting, but that hasn’t stopped this AIM company paying what…
Results and updates covered here include those of several consistent (and highly-rated) performers, but a potential…
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world…
Our high yield portfolio is on track to deliver a 5.9% dividend yield in 2023, substantially…
Our dividend stocks are continuing to report robust performances despite the impact of inflation and slowing…
A trading update from one of AIM’s more elderly constituents offers the usual reassurance, but this…
Results and updates covered here include simplicity and excellence from an AIM elder and complexity and…
Results and updates covered here include yet more disappointment for shareholders of online wine retailer Naked…
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world…
Results and updates covered here suggest all is well for these fast-growing AIM companies, with several…
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world…
Better than expected
Stonking stitch-up! | Bonkers Bargain delights
Wonderful cash flow | AIM newcomer | Director buying
DUKE of hazard | Bonkers Bargain ahead again
Worrying business models | Elderly simplicity
Bonkers deal of the week or another nifty acquisition?
Strong updates to enjoy
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Income Boosters: 2022 portfolio review
Income Boosters: earnings boost for FTSE 100 stalwart
AIM elder is steady as ever | What’s in a name?
Worrying business models | Elderly simplicity
Naked Wines: stripping shareholders bare
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Positive updates | Strange share price moves
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
More Company Insights
Focus on the cash flow
Better than expected
Plenty of waffle
Dieselgate could deliver big returns for this company
Stonking stitch-up! | Bonkers Bargain delights
Wonderful cash flow | AIM newcomer | Director buying
A high-quality business delivers
Upgrades and a horror show!
DUKE of hazard | Bonkers Bargain ahead again
Worrying business models | Elderly simplicity
Beneficiary of rising interest rates
Where a 7% dividend yield hides a multitude of issues
Bonkers deal of the week or another nifty acquisition?
Strong updates to enjoy
Hydrogen potential here
Bonkers Bargain updates
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Income Boosters: 2022 portfolio review
Income Boosters: earnings boost for FTSE 100 stalwart
Income Boosters update: these yields look safe
Income Boosters - June ‘22 portfolio update
AIM elder is steady as ever | What’s in a name?
Worrying business models | Elderly simplicity
Big sell-off brings Director buying!
Another IPO from 2021 tumbles
Naked Wines: stripping shareholders bare
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Vaccine countdown update: 10 Nov - positive results from some, cash flow concerns with others
Coronavirus impact: 14 July - plenty of updates and a bizarre response from Manolete
Positive updates | Strange share price moves
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
US software stocks shine in lockdown
Coronavirus crash victims: is the only way up?
More Company Insights
Bonkers Bargains: yielding more than 6%
Benefit from the boom in healthcare Artificial Intelligence (updated)
Load of waffle | Uranium is hot | Contract wins
